INDUSTRY: Healthcare
TARGETED AUDIENCE: Pulmonologist
COUNTRY: UK & FRANCE
BACKGROUND & KEY OBJECTIVES:
- The study’s goal was to determine the ratio of Pulmonary Arterial Hypertension (PAH) patients treated by a pulmonologist in the previous 12 months and overall in terms of symptoms, WHO patient classification groups, available treatment options, and doctor-prescribed regimens.
- The survey questions primarily targeted patients treated at the entire practice/treatment center, with the distribution of Lines of Therapy received in the previous year and personally initiated treatment classes such as ERAs, PDE-5is, Oral Prostacyclin IP receptors, etc.
- To determine which Regimens (Monotherapies & Combination Therapies) are prescribed by their pulmonologist for patients with pulmonary arterial hypertension.
METHODOLOGIES & APPROACH:
- A probability sample of hospital-based pulmonologists who diagnose and treat patients with pulmonary arterial hypertension (PAH).
- Length of quantitative survey: 30 Minutes
- Targeted countries: UK & France
- The survey contains questions in several sections:
- Patient segmentation
- Treatment Plan
- Available and in-development regimens
- Pulmonologist-preferred regimens
OUR SOLUTION:
- The above study provided the customer with information on the overall distribution of Pulmonary Arterial Hypertension (PAH) patients.
- Initial input on accessible market regimens generally favored by pulmonologists to address patients’ problems.